ConductScience.org, home

Paper23946647

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors.

Ferris SH and 1 other. Clin Interv Aging, 2013. Cited by 82 papers, by iCite.

Cite this record

ConductScience Library. Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors. Papers, record 23946647. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23946647

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors.
PubMed
Journal
Clin Interv Aging
PubMed
Year
2013
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
82
iCite
Relative citation ratio, by iCite
3.2
iCite
Revised in PubMed
2022-03-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ferris SHSteven H
2Farlow MMartin

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Cholinesterase InhibitorsMajor topic
Communication DisordersMajor topic
Donepezil
Galantamine
Humans
Indans
Outcome Assessment, Health Care
Phenylcarbamates
Piperidines
Rivastigmine

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30 AG008051NIA NIH HHSUnited StatesP30AG008051PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121131668Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's disease.Am J Alzheimers Dis Other Demen2010https://conductscience.org/library/papers/21131668PubMed
215306548The effects of ageing and Alzheimer's disease on semantic and gender priming.Brain2004https://conductscience.org/library/papers/15306548PubMed
316209425Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease.J Int Neuropsychol Soc2005https://conductscience.org/library/papers/16209425PubMed
420395684Cognition and function in Alzheimer's disease: identifying the transitions from moderate to severe disease.Dement Geriatr Cogn Disord2010https://conductscience.org/library/papers/20395684PubMed
522119074What are the important factors in health-related quality of life for people with aphasia? A systematic review.Arch Phys Med Rehabil2012https://conductscience.org/library/papers/22119074PubMed
620678673Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.Clin Ther2010https://conductscience.org/library/papers/20678673PubMed
712925369Alzheimer disease in the US population: prevalence estimates using the 2000 census.Arch Neurol2003https://conductscience.org/library/papers/12925369PubMed
819042161Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.Lancet Neurol2009https://conductscience.org/library/papers/19042161PubMed
919735164Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials.Curr Med Res Opin2009https://conductscience.org/library/papers/19735164PubMed
106496779A new rating scale for Alzheimer's disease.Am J Psychiatry1984https://conductscience.org/library/papers/6496779PubMed
1110844704Measurement of progression in Alzheimer's disease: a clinician's perspective.Stat Med2000https://conductscience.org/library/papers/10844704PubMed
1212456059Measuring cognition in advanced Alzheimer's disease for clinical trials.J Neural Transm Suppl2002https://conductscience.org/library/papers/12456059PubMed
1316581404Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.Lancet2006https://conductscience.org/library/papers/16581404PubMed
1411502918A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.Neurology2001https://conductscience.org/library/papers/11502918PubMed
159236953The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.Alzheimer Dis Assoc Disord1997https://conductscience.org/library/papers/9236953PubMed
1618560130Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease.J Alzheimers Dis2008https://conductscience.org/library/papers/18560130PubMed
1715643047Investigating the effects of communication problems on caregiver burden.J Gerontol B Psychol Sci Soc Sci2005https://conductscience.org/library/papers/15643047PubMed
1820220536The relationship of 60 disease diagnoses and 15 conditions to preference-based health-related quality of life in Ontario hospital-based long-term care residents.Med Care2010https://conductscience.org/library/papers/20220536PubMed
1920392862Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease.Am J Alzheimers Dis Other Demen2010https://conductscience.org/library/papers/20392862PubMed
2020580129Alzheimer's pathology in primary progressive aphasia.Neurobiol Aging2012https://conductscience.org/library/papers/20580129PubMed

See all 35 referencesDownload CSV of references

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.

PMIDTitleJournalYearIn PapersSource
42562373How Life-Course Trajectories of Physical Activity Track With Cognitive Decline.J Phys Act Health2026https://conductscience.org/library/papers/42562373PubMed
42356806Enhancing Early Detection of Alzheimer's Disease: An Ensemble Model for Multi-Domain Cognitive Assessment Using Voice and Video.Sensors (Basel)2026https://conductscience.org/library/papers/42356806PubMed
42301821Considerations for the selection and phenotyping of mouse models for the study of Alzheimer's disease.STAR Protoc2026https://conductscience.org/library/papers/42301821PubMed
42208039Recruitment and Participation of Black Home Health Care Patients in Speech-Based Cognitive Research: Mixed Methods Feasibility Study.JMIR Form Res2026https://conductscience.org/library/papers/42208039PubMed
42131727Functional ability in cognitive complaints: The role of neuropsychiatric and cognitive factors in community-dwelling older adults.Alzheimers Dement Behav Socioecon Aging2025https://conductscience.org/library/papers/42131727PubMed
41801850Timed image naming evaluation for adults (TIME) using BOSS images.PLoS One2026https://conductscience.org/library/papers/41801850PubMed
41403033Speech and language outcome measures in clinical trials of Alzheimer's and Parkinson's diseases.Expert Rev Neurother2026https://conductscience.org/library/papers/41403033PubMed
41302276Linguistic Markers in Spontaneous Speech: Insights into Subjective Cognitive Decline (Review).Healthcare (Basel)2025https://conductscience.org/library/papers/41302276PubMed
40913642Language dysfunction as a primary feature of cognitive decline in neurological populations.J Neural Transm (Vienna)2026https://conductscience.org/library/papers/40913642PubMed
40249550Visuospatial impairment in dementia: a new index to improve the clinical diagnosis of Alzheimer's disease.Aging Clin Exp Res2025https://conductscience.org/library/papers/40249550PubMed
39796512Mechanistic and Therapeutic Insights into Flavonoid-Based Inhibition of Acetylcholinesterase: Implications for Neurodegenerative Diseases.Nutrients2024https://conductscience.org/library/papers/39796512PubMed
39684990Perceived Training Needs of the Informal Caregivers of Older Adults: A Cross-Sectional Study.Healthcare (Basel)2024https://conductscience.org/library/papers/39684990PubMed
39163290Speech-related parameters are sensitive measures of acetylcholinesterase inhibitor therapy in mild Alzheimer's disease.PLoS One2024https://conductscience.org/library/papers/39163290PubMed
39114543Language Markers of Dementia and Their Role in Early Diagnosis of Alzheimer's Disease: Exploring Grammatical and Syntactic Competence via Sentence Repetition.J Alzheimers Dis Rep2024https://conductscience.org/library/papers/39114543PubMed
39028554Algorithmic Spaced Retrieval Enhances Long-Term Memory in Alzheimer Disease: Case-Control Pilot Study.JMIR Form Res2024https://conductscience.org/library/papers/39028554PubMed
37389678Validation of the test for finding word retrieval deficits (WoFi) in detecting Alzheimer's disease in a naturalistic clinical setting.Eur J Ageing2023https://conductscience.org/library/papers/37389678PubMed
37341896Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System.CNS Drugs2023https://conductscience.org/library/papers/37341896PubMed
37035940Complementary auditory and Visual Naming Tests: Revised and updated for ages 16-55 years.Clin Neuropsychol2024https://conductscience.org/library/papers/37035940PubMed
36819782A Multifunctional (-)-Meptazinol-Serotonin Hybrid Ameliorates Oxidative Stress-Associated Apoptotic Neuronal Death and Memory Deficits via Activating the Nrf2/Antioxidant Enzyme Pathway.Oxid Med Cell Longev2023https://conductscience.org/library/papers/36819782PubMed
36737766The impact of depression on language function in individuals with Alzheimer's disease: a pre/post-treatment design.Ann Gen Psychiatry2023https://conductscience.org/library/papers/36737766PubMed

See all 52 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ACHE43PubTator's text mininghttps://conductscience.org/library/genes/43

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23946647

GET https://conductscience.org/api/papers/v1/23946647/references?page=2